Tag: Gilead Sciences Inc
Retailers present early indicators of restoration; AstraZeneca ramps up antibody research
Whilst some international locations, significantly these first hit by the coronavirus, present some constructive indicators of enchancment, the Wor [...]
AstraZeneca approached Gilead about merger
White Home well being advisor Dr. Anthony Fauci has mentioned the coronavirus outbreak within the U.S. seems to be entering into "the precise route [...]
Early trial outcomes for potential coronavirus remedies anticipated in three weeks, WHO says
Nurse Cao Shan put together medicines for sufferers in Jinyintan Hospital, designated for COVID-19 sufferers, in Wuhan in central China's Hubei pro [...]
‘I am not going towards Alibaba’
BlackBerry: "Properly, he was flawed and that is attention-grabbing. That man do not go breaking my coronary heart with that inventory. ... Do not [...]
Here is your information to biotech firms engaged on coronavirus
A nurse holds up a one dose bottle and a ready syringe of measles, mumps and rubella virus vaccine made by Merck on the Utah County Well being Divi [...]
US fast-tracks coronavirus vaccine, hopes to begin trial in three months
Amid issues concerning the Coronavirus inflicting sickness and deaths in China, many parade goers throughout New York Metropolis, New York's annual [...]
Medical wonders, looser FDA made biotech a high funding since 2010
Alex Raths | Getty PhotographsBiotechnology was one of many decade's finest investments as a dizzying tempo of medical innovation fueled the invent [...]
Apple, Adobe, Hanes & extra
Apple CEO Tim Prepare dinner greets prospects as they put together to buy a brand new iPhone X at an Apple Retailer on November 3, 2017 in Palo Alt [...]
Intel, Gilead Sciences, Visa and extra
An attendee wears a Genius VR headset on the Intel sales space throughout CES 2019 shopper electronics present, January 10, 2019 on the Las Vegas C [...]
Biotech shares soar following shock Biogen drug announcement
Biotech shares surged after Biogen introduced plans to revive its Alzheimer's drug aducanumab.The iShares NASDAQ Biotechnology ETF gained greater t [...]